TY - JOUR
T1 - ARID5B regulates metabolic programming in human adaptive NK cells
AU - Cichocki, Frank M
AU - Wu, Cheng-Ying
AU - Zhang, Bin
AU - Felices, Martin
AU - Tesi, Bianca
AU - Tuininga, Katie
AU - Dougherty, Phillip
AU - Taras, Emily
AU - Hinderlie, Peter
AU - Blazar, Bruce R
AU - Bryceson, Yenan T.
AU - Miller, Jeffrey S
N1 - Publisher Copyright:
© 2018 Cichocki et al.
PY - 2018
Y1 - 2018
N2 - Natural killer (NK) cells with adaptive immunological properties expand and persist in response to human cytomegalovirus. Here, we explored the metabolic processes unique to these cells. Adaptive CD3−CD56 dim CD57 + NKG2C + NK cells exhibited metabolic hallmarks of lymphocyte memory, including increased oxidative mitochondrial respiration, mitochondrial membrane potential, and spare respiratory capacity. Mechanistically, we found that a short isoform of the chromatin-modifying transcriptional regulator, AT-rich interaction domain 5B (ARID5B), was selectively induced through DNA hypomethylation in adaptive NK cells. Knockdown and overexpression studies demonstrated that ARID5B played a direct role in promoting mitochondrial membrane potential, expression of genes encoding electron transport chain components, oxidative metabolism, survival, and IFN-γ production. Collectively, our data demonstrate that ARID5B is a key regulator of metabolism in human adaptive NK cells, which, if targeted, may be of therapeutic value.
AB - Natural killer (NK) cells with adaptive immunological properties expand and persist in response to human cytomegalovirus. Here, we explored the metabolic processes unique to these cells. Adaptive CD3−CD56 dim CD57 + NKG2C + NK cells exhibited metabolic hallmarks of lymphocyte memory, including increased oxidative mitochondrial respiration, mitochondrial membrane potential, and spare respiratory capacity. Mechanistically, we found that a short isoform of the chromatin-modifying transcriptional regulator, AT-rich interaction domain 5B (ARID5B), was selectively induced through DNA hypomethylation in adaptive NK cells. Knockdown and overexpression studies demonstrated that ARID5B played a direct role in promoting mitochondrial membrane potential, expression of genes encoding electron transport chain components, oxidative metabolism, survival, and IFN-γ production. Collectively, our data demonstrate that ARID5B is a key regulator of metabolism in human adaptive NK cells, which, if targeted, may be of therapeutic value.
UR - http://www.scopus.com/inward/record.url?scp=85055884415&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85055884415&partnerID=8YFLogxK
U2 - 10.1084/jem.20172168
DO - 10.1084/jem.20172168
M3 - Article
C2 - 30061358
AN - SCOPUS:85055884415
SN - 0022-1007
VL - 215
SP - 2379
EP - 2395
JO - Journal of Experimental Medicine
JF - Journal of Experimental Medicine
IS - 9
ER -